donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 03933 UNITED LAB > Key Indicators
03933 UNITED LAB
4.770
+0.120+2.58%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Per Share IndicaTor
Operating Cash Flow Per Share
1.53% 1.0286 37.21% 0.5652 -17.38% 1.0131 -25.75% 0.4119
Cash Flow Per Share
299.63% 0.223 737.2% 0.3452 -109.73% -0.1117 -107.46% -0.0542
Operating Income Per Share
14.25% 6.4705 18.51% 3.0816 -0.88% 5.6635 -8.3% 2.6002
Net Asset Per Share
12% 6.2285 25.36% 5.9361 22.43% 5.5611 8.11% 4.7354
Basic Earning Per Share
38.86% 0.6568 210.53% 0.4069 8.25% 0.473 -36.14% 0.131
Diluted  Earning Per Share
38.86% 0.6568 210.53% 0.4069 8.25% 0.473 -36.14% 0.131
Profitability
Gross Profit Ratio
0.02% 43.397% 6.33% 44.413% 0.56% 43.388% -0.74% 41.769%
Operating Profit Ratio
-17.16% 13.015% 1.73% 15.990% 6.97% 15.711% 48.72% 15.718%
Net Profit Ratio
27.64% 10.198% 180.9% 13.236% 4.49% 7.990% -34.87% 4.712%
Earning Before Tax Ratio
23.23% 12.394% 102.14% 15.304% 0.29% 10.058% -8.05% 7.571%
ROE
18.13% 11.160% 155.47% 7.078% -4.72% 9.447% -41.59% 2.770%
ROA
35.31% 6.402% 212.16% 4.067% 13.04% 4.732% -34.06% 1.303%
Yield Quality
Operating Profit To Total Profits
-32.77% 105.008% -49.67% 104.481% 6.66% 156.202% 61.74% 207.612%
Tax To Total Profits
13.84% -17.716% 64.22% -13.512% 13.43% -20.561% -211.39% -37.761%
Operating Cash To Total Revenue
-11.13% 15.897% 15.78% 18.342% -16.65% 17.888% -19.03% 15.842%
Capital Structure
Debt Assets Ratio
0.85% 42.809% -11.49% 42.652% -26.18% 42.449% -17.78% 48.191%
Equity Multipler
0.65% 1.7484 -9.66% 1.7436 -26.18% 1.7372 -20.11% 1.9302
Debt Equity Ratio
1.49% 74.853% -20.04% 74.373% -45.49% 73.758% -34.31% 93.016%
Current Assets To tatal Assets
11.25% 61.149% 9.02% 59.359% -0.96% 54.966% 9.73% 54.450%
Non Current Assets To Total Assets
-13.73% 38.851% -10.78% 40.641% 1.2% 45.034% -9.58% 45.550%
Current Liabilities To tatal Liabilities
22.18% 93.478% 29.53% 83.502% 6.94% 76.511% -28% 64.465%
Non Current Liabilities To Total Liabilities
-72.23% 6.522% -53.57% 16.498% -17.46% 23.489% 239.61% 35.535%
Solvency
Current Ratio
-9.71% 1.5281 -4.91% 1.6667 25.45% 1.6924 85.34% 1.7527
Quick Ratio
-12.66% 1.2214 -3.6% 1.3738 26.54% 1.3985 88.65% 1.4252
Operating Profit To Current Liabilities
-31.86% 0.1932 -7.13% 0.1337 48.6% 0.2836 166.71% 0.1439
Operrating Cash Flow To Current Liabilities
-26.9% 0.236 5.69% 0.1533 15.79% 0.3229 45.22% 0.1451
Share Equity Without Minority Interest To Total Liabilities
-1.48% 1.336 25.08% 1.3447 83.5% 1.3561 52.23% 1.0751
Operating Cash Flow To Total Liabilities
-10.69% 0.2206 36.9% 0.128 23.83% 0.2471 4.55% 0.0935
Operating Profit To Total Liabilities
-16.75% 0.1806 20.29% 0.1116 58.92% 0.217 92.03% 0.0928
Operating Capacity
Current Assets Turnover(T)
0.99% 1.0796 7.03% 0.5381 -0.8% 1.069 -12.03% 0.5028
Fixed Assets Turnover(T)
12.07% 1.6427 14% 0.7868 12.23% 1.4658 8.05% 0.6902
Total Assets Turnover(T)
6.48% 0.6287 11.41% 0.308 7.86% 0.5905 1.25% 0.2765
Growth Ability
Operating Revenue GR 3Y
39.19% 38.457% 16.06% 26.072% -15.4% 27.629% -31.32% 22.465%
Gross Income GR 3Y
61.53% 36.059% 35.47% 24.015% -16.06% 22.323% -37.28% 17.727%
Operating Profit GR 3Y
-73.49% 66.621% -78.65% 39.965% -49.88% 251.323% 69.97% 187.172%
EBT GR 3Y
-94.68% 62.348% 277.28% 390.465% 65.4% 1170.942% -63.24% 103.494%
Net Profit GR 3Y
-92.64% 55.289% 675.57% 594.134% 127.62% 751.471% -96.71% 76.606%
Net Profit Attributable To The Parent Company GR 3Y
-92.7% 55.056% 673.34% 592.420% 128.38% 753.987% -96.71% 76.606%
Total Assets GR 3Y
302.68% 19.575% 526.88% 11.428% -5.45% 4.861% -328.6% -2.677%
Share Equity Without Minority Interest GR 3Y
11.65% 63.124% 82.81% 66.634% 129.03% 56.538% 285.26% 36.450%
Equity GR 3Y
11.71% 63.114% 82.78% 66.625% 128.88% 56.500% 285.26% 36.450%
Total Liabilities GR 3Y
56.96% -11.857% 10.55% -22.909% -377.13% -27.550% -545.83% -25.610%
Basic Earning Per Share GR 3Y
-94.51% 37.677% 637.62% 512.651% 108.91% 686.064% -96.99% 69.501%
Net Assets Per Share GR 3Y
19.42% 45.828% 115.54% 48.465% 61.87% 38.377% 161.35% 22.486%
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Federal Pharmaceutical International Holdings Co., Ltd. is an investment holding company, mainly engaged in the sale of intermediate products, API and preparation products. The company operates through three business units. The intermediate department is engaged in the business of selling intermediate products. The API Department is engaged in the business of selling APIs. The preparation products Department is engaged in the sales of antibiotic preparation products, non-antibiotic preparation products and hollow capsules. The company, through its subsidiaries, is also engaged in the manufacture and sale of organic fertilizers.
CEO: Haishan Cai
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...